Lifestyle Interventions for Vitality and Empowerment in Seniors

NCT ID: NCT05631106

Last Updated: 2022-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-30

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to test a newer type of high intensity interval resistance training in adults 65 years of age or older. The main aims of this study are:

1. To develop study procedures in order to conduct a randomized controlled trial to test the impact of high intensity interval training on cognition in older adults. We will develop procedures for recruitment, screening, data collection, blinded randomization, HIIRT and EA interventions, safety monitoring, and data analyses.
2. To determine the feasibility of using high intensity interval resistance training as an intervention. Feasibility will be shown by; 1) recruiting the target population and meeting our overall patient accrual goal of 30 participants over a 12-week period, 2) achieving an average attendance rate of ≥ 70% of the 24 scheduled sessions in the HIIRT group, 3) at least 80% retention of participants at the final follow-up assessment (week 12), and 4) successful completion of the MRI task (finishing the session with a behavioral accuracy greater than 70%) by at least 80% of participants. Acceptability will be assessed via participants' ratings on a standardized measure of treatment satisfaction and reasons for dropout. Acceptability will be indicated in 2 ways: 70% of the participants report treatment satisfaction on a standard questionnaire, and consistent collection of follow-up data across sites.
3. To examine causal mechanisms and preliminary efficacy. We will examine the relationships among several proposed mediators of the expected treatment effect. We will also examine the mean change and variability of our primary outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Change

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Control Trial
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stretching, Balance, Range of Motion

Participants will engage stretching, balance, and range of motion exercises 2 days per week for 12-weeks.

Group Type ACTIVE_COMPARATOR

Stretching, Balance, and Range of motion

Intervention Type BEHAVIORAL

The stretching, balance, and range of motion intervention will include a rotating and varied routine of stretching exercises for large and small muscle groups, and activities to improve balance and range of motion. Participants will attend this intervention twice a week with each session lasting 30 minutes.

High Intensity Interval Resistance Training

Participants will perform resistance training exercises at high intensity intervals 2 days per week for 12-weeks.

Group Type EXPERIMENTAL

High Intensity Interval Resistance Training

Intervention Type BEHAVIORAL

During each group exercise session, the participants will be guided through a 5-minute warm-up, supervised to perform two sets of machine-based leg press, chest press, seated row, and shoulder press exercises at 30% of 1-RM, and guided through a cool-down. Each exercise set will be 40 -seconds in length with instructions to perform as many repetitions as possible followed by a 20-second rest in between sets and a three-minute rest between exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Intensity Interval Resistance Training

During each group exercise session, the participants will be guided through a 5-minute warm-up, supervised to perform two sets of machine-based leg press, chest press, seated row, and shoulder press exercises at 30% of 1-RM, and guided through a cool-down. Each exercise set will be 40 -seconds in length with instructions to perform as many repetitions as possible followed by a 20-second rest in between sets and a three-minute rest between exercises.

Intervention Type BEHAVIORAL

Stretching, Balance, and Range of motion

The stretching, balance, and range of motion intervention will include a rotating and varied routine of stretching exercises for large and small muscle groups, and activities to improve balance and range of motion. Participants will attend this intervention twice a week with each session lasting 30 minutes.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lives within 20 miles of the school
* Does not plan to travel outside the home geographic area for an extended period during the study participation
* Willing to provide informed consent
* Willing to be randomized to either lifestyle intervention group
* Willing to complete all study procedures and assessments
* No contraindications to exercise
* Capacity to complete physical exercise

Exclusion Criteria

* Dependent on walking device
* Claustrophobia
* Performs 30 minutes of moderate intensity exercise three times per week for the previous three months
* Joint replacement or orthopedic surgery in the previous 6-months or planning to have surgery in the next 6-months
* Uncontrolled hypertension
* Pathological neurological condition
* Parkinson's disease
* Unstable depression, anxiety, or schizophrenia (medication changes in the past 6 months)
* Experienced a concussion within the last 6 months
* Respiratory disease requiring oxygen
* Cancer requiring treatment
* Osteoarthritis
* Osteopenia or Osteoporosis
* Body mass index under 18
* Muscle wasting disease
* Hypertrophic or dilated cardiomyopathy significant cardiovascular disease (NIHA Class III/IV congestive heart failure, aortic stenosis, history of cardiac arrest, uncontrolled angina)
* Currently receiving physical therapy or cardiopulmonary rehabilitation
* Type I or insulin dependent Type II Diabetes
* Any implanted medical devices that are not compatible with fMRI scans (cardiac pacemaker or implanted cardiac defibrillator (ICD))
* Metal shavings in eyes
* Ferromagnetic piercings that cannot be taken out
* Transdermal patches that cannot be removed
* Cerebral aneurysm clip
* \>14 alcoholic drinks in one week
* Not receiving medical clearance after PARQ+
* Evidence of cognitive impairment (Scoring below 32 points on the Telephone Interview of Cognitive Status)
* Site PI/Study Clinician discretion regarding medical status, appropriateness of participation or concern about intervention adherence, clinical judgement
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wake Forest University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jeff Katula

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jeffery A Katula, Ph.D

Role: CONTACT

Phone: (336) 758-3612

Email: [email protected]

Anthony Sali, Ph.D

Role: CONTACT

Phone: (336) 758-4813

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00024800

Identifier Type: -

Identifier Source: org_study_id